Skip to content

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

Multi-reader, Multi-case, Observer-blind, Retrospective, Pivotal Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer During Screening Mammography Interpretation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05615298
Enrollment
240
Registered
2022-11-14
Start date
2020-06-15
Completion date
2021-01-13
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study aims to evaluate Effectiveness of Investigational Device, Lunit INSIGHT MMG, in the assistance of Detection and Diagnosis of Breast Cancer during Screening Mammography Interpretation.

Detailed description

The Lunit INSIGHT MMG is developed as a computer-assisted detection/diagnosis device based on deep learning technology. In this pivotal study, effectiveness of the investigational device, Lunit INSIGHT MMG, was examined by comparing the reading panelist's interpretation ability between CAD assisted and unassisted during screening mammography interpretation.

Interventions

RADIATIONMammography

FFDM (Full-Field Digital mammography)

Sponsors

Lunit Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Female * Any ethnic origin * Acquired with devices from two manufacturers: Hologic and GE * 4 views (RMLO, LMLO, RCC, LCC) images of FFDM (Full-Field Digital mammography)

Exclusion criteria

* Previous core needle biopsy in breast for past 2 years * Previous vacuum-assisted biopsy, surgical biopsy or surgery in breast * Previous breast cancer * Lactating when taking screening mammograms * Presence of a breast implant in screening mammograms * Presence of a pacemaker in screening mammograms * Inadequate quality status such as insufficient anatomical coverage of screening mammograms

Design outcomes

Primary

MeasureTime frameDescription
Patient-level FBR (forced BI-RADS) area under the Receiver Operating Characteristic (ROC) curveThrough study completion, an average of 6 monthsPatient-level FBR (forced BI-RADS) area under the Receiver Operating Characteristic (ROC) curve to measure the effectiveness of Investigational Device between CAD assited and unassisted environment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026